Details

Details

Title Utility of Early Versus Late Androgen Deprivation in Prostate Cancer Patients with Biochemical Relapse

IRB CASE 1811

CC CC00032

Hospital Main Campus

Stage N/A

Phase N/A

Disease Prostate

Description

Description

  1. To measure the utility of treatment versus observation in patients with rising PSA
Inclusion Criteria

Inclusion Criteria

  1. All patients with rising PSA after definitive treatment of their prostate cancer with no evidence of metastatic disease are eligible for this study.
  2. The patient population includes patients with biochemical failure who are being followed at Taussig Cancer Institute or at Glickman clinics.
  3. The patient will be informed that their choice of whether to participate or not will have no influence on their medical care.
Exclusion Criteria

Exclusion Criteria

Exclusion Criteria Not Available